These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 34119317)

  • 1. COVID-19 vaccines: A perspective from social pharmacology.
    Montastruc JL; Lafaurie M; de Canecaude C; Montastruc F; Bagheri H; Durrieu G; Sommet A
    Therapie; 2021; 76(4):311-315. PubMed ID: 34119317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protecting refugees during the COVID-19 pandemic.
    The Lancet
    Lancet; 2021 Jun; 397(10292):2309. PubMed ID: 34147144
    [No Abstract]   [Full Text] [Related]  

  • 4. Benefits and risks associated with different uses of the COVID-19 vaccine Vaxzevria: a modelling study, France, May to September 2021.
    Tran Kiem C; Andronico A; Bosetti P; Paireau J; Alter L; Boëlle PY; Fontanet A; Lévy-Bruhl D; Cauchemez S
    Euro Surveill; 2021 Jul; 26(26):. PubMed ID: 34212840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 updates: Moderna COVID-19 vaccine (Spikevax) gains full licensure.
    Med Lett Drugs Ther; 2022 Feb; 64(1644):32. PubMed ID: 35175715
    [No Abstract]   [Full Text] [Related]  

  • 6. A Public Health COVID-19 Vaccination Strategy to Maximize the Health Gains for Every Single Vaccine Dose.
    Barnabas RV; Wald A
    Ann Intern Med; 2021 Apr; 174(4):552-553. PubMed ID: 33395339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 vaccines and treatments nationalism: Challenges for low-income countries and the attainment of the SDGs.
    Nhamo G; Chikodzi D; Kunene HP; Mashula N
    Glob Public Health; 2021 Mar; 16(3):319-339. PubMed ID: 33317389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 Vaccine: Promoting Vaccine Acceptance.
    Laine C; Cotton D; Moyer DV
    Ann Intern Med; 2021 Feb; 174(2):252-253. PubMed ID: 33347321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of COVID-19 vaccines: Several modes of expression should be presented in scientific publications.
    Montastruc JL; Biron P; Sommet A
    Fundam Clin Pharmacol; 2022 Feb; 36(1):218-220. PubMed ID: 34250637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unfolding the Determinants of COVID-19 Vaccine Acceptance in China.
    Yin F; Wu Z; Xia X; Ji M; Wang Y; Hu Z
    J Med Internet Res; 2021 Jan; 23(1):e26089. PubMed ID: 33400682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toward Achieving a Vaccine-Derived Herd Immunity Threshold for COVID-19 in the U.S.
    Gumel AB; Iboi EA; Ngonghala CN; Ngwa GA
    Front Public Health; 2021; 9():709369. PubMed ID: 34368071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Covid-19 vaccination and renal patients: overcoming unwarranted fears and re-establishing priorities].
    Sciarrone Alibrandi MT; Vespa M; Joli G; Bucci R; Brioni E; Rivera RF
    G Ital Nefrol; 2021 Apr; 38(2):. PubMed ID: 33852219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [SARS-CoV-2 vaccines].
    Benfield TL; Helweg-Larsen J
    Ugeskr Laeger; 2021 Mar; 183(10):. PubMed ID: 33734065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained COVID-19 vaccine willingness after safety concerns over the Oxford-AstraZeneca vaccine.
    Sønderskov KM; Dinesen PT; Østergaard SD
    Dan Med J; 2021 Mar; 68(5):. PubMed ID: 33870886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Misrepresentation about vaccines that are scaring women.
    Moodley J; Khaliq OP; Mkhize PZ
    Afr J Prim Health Care Fam Med; 2021 Jun; 13(1):e1-e2. PubMed ID: 34212737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.
    Lambert PH; Ambrosino DM; Andersen SR; Baric RS; Black SB; Chen RT; Dekker CL; Didierlaurent AM; Graham BS; Martin SD; Molrine DC; Perlman S; Picard-Fraser PA; Pollard AJ; Qin C; Subbarao K; Cramer JP
    Vaccine; 2020 Jun; 38(31):4783-4791. PubMed ID: 32507409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Canada is no global health leader on COVID-19 vaccine equity.
    Houston AR; Murthy S
    Lancet; 2021 May; 397(10287):1803. PubMed ID: 33992135
    [No Abstract]   [Full Text] [Related]  

  • 18. Prospects of COVID-19 Vaccination in Romania: Challenges and Potential Solutions.
    Dascalu S; Geambasu O; Covaciu O; Chereches RM; Diaconu G; Dumitra GG; Gheorghita V; Popovici ED
    Front Public Health; 2021; 9():644538. PubMed ID: 33643998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccine Hesitancy and COVID-19: Nursing's Role.
    Enriquez M
    Hisp Health Care Int; 2021 Jun; 19(2):74. PubMed ID: 33984251
    [No Abstract]   [Full Text] [Related]  

  • 20. Alternative Dose Allocation Strategies to Increase Benefits From Constrained COVID-19 Vaccine Supply.
    Tuite AR; Zhu L; Fisman DN; Salomon JA
    Ann Intern Med; 2021 Apr; 174(4):570-572. PubMed ID: 33395334
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.